Matthew S. Abbott
Known title: SVP, CIOCIK: 0001786056
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Chemours Q2 Earnings Call and UBS Price Target Cut. Chemours released its Q2 2026 earnings call transcript, providing details on its financial performance. UBS kept a neutral stance but lowered its price target to $16, reflecting a more cautious view of the company's outlook. The new target sits below the current average analyst target of $18.22 and near the support level of $15.07, indicating a potential short‑term pressure on the stock.
Transaction History
| DD | ▼ Sell | Tax Withholding | 805 | $41K | 2/21/2026 | View on chart |
| DD | ▲ Buy | Grant | 5,158 | $0 | 2/20/2026 | View on chart |
| CC | ▼ Sell | Tax Withholding | 453 | $11K | 8/1/2024 | View on chart |
| CC | ▲ Buy | Grant | 11,818 | $0 | 5/8/2024 | View on chart |
| CC | ▲ Buy | Grant | 6,331 | $0 | 3/27/2024 | View on chart |
| CC | ▼ Sell | Tax Withholding | 2,039 | $59K | 3/27/2024 | View on chart |
| CC | ▼ Sell | Tax Withholding | 4,415 | $92K | 3/1/2024 | View on chart |
| CC | ▲ Buy | Grant | 4,069 | $0 | 8/1/2023 | View on chart |
| CC | ▲ Buy | Option Exercise | 8,912 | $129K | 6/8/2023 | View on chart |
| CC | ▼ Sell | Open Market | 8,912 | $305K | 6/8/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
DuPont receives analyst upgrades and announces quarterly dividend
DuPont de Nemours was highlighted in several recent analyst reports. RBC Capital kept an Outperform rating while lowering its price target to $160, and Barclays began coverage with an Overweight rating and a $156 target. The company also announced its regular quarterly dividend for common stock. These developments show ongoing analyst attention and a focus on returning cash to shareholders.
DuPont receives analyst upgrades and announces quarterly dividend. DuPont de Nemours was highlighted in several recent analyst reports. RBC Capital kept an Outperform rating while lowering its price target to $160, and Barclays began coverage with an Overweight rating and a $156 target. The company also announced its regular quarterly dividend for common stock. These developments show ongoing analyst attention and a focus on returning cash to shareholders.